Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients

Current Vascular Pharmacology

Volumn 13, Issue 2, 2015, Pages 248-258

  Fusaro, Maria ^a   Tripepi, Giovanni ^a   Noale, Marianna ^a   Plebani, Mario ^b   Zaninotto, Martina ^b   Piccoli, Antonio ^c   Naso, Agostino ^b   Miozzo, Davide ^c   Giannini, Sandro ^c   Avolio, Marco ^c   Foschi, Annalisa ^d   Rizzo, Maria Antonietta ^e   Gallieni, Maurizio ^e   Vilei, M T ^f   Tineo, M C ^f   Rebeschini, M ^f   Naso, A ^f   Grimaldi, C ^f   Mannarino, A ^f   Ciurlino, D ^g   Bertoli, S ^g   Puggia, R ^f   Caberlotto, A ^f   Mastrosimone, S ^f   Cascone, C ^f   Corradini, R ^f   Avolio, M ^f   Giacon, B ^f   Foschi, A ^h   Barbieri, C ^h   Milanesi, F ^h   Pica, A ^f   Venturelli, C ^f   Brunori, G ^f   Pati, T ^f   Gemelli, A ^f   Bernardi, A M ^f   Barbisoni, F ^f   Elli, A ^f   Morachiello, P ^f   Feriani, M ^f   Stoppa, F ⁱ   Tarroni, G ^f   De Paoli Vitali, E ^f   Lucatello, S ^j   Meneghel, G ^j   Vianello, A ^k   Antonucci, F ^k   Pellanda, V ^l   Dell'Aquila R ^l   Ferraro, A ^m   De Luca, M ^m   Magonara, F M ⁿ   Axia, M ⁿ   Spinello, M ^o   Urso, M ^o   more..

^a CNR   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d General Hospital of Voghera   (Italy)

^e SAN CARLO BORROMEO HOSPITAL   (Italy)

^f Hospital of Voghera ^*  (Italy)

^g Sesto San Giovanni Hospital   (Italy)

^h Milan ^*  (Italy)

ⁱ NONE   (Italy)

^j NONE   (Italy)

^k Feltre Hospital   (Italy)

^l NONE   (Italy)

^m Castelfranco Veneto Hospital   (Italy)

ⁿ NONE   (Italy)

^o Chioggia Civil Hospital   (Italy)

more..

Author keywords

Hemodialysis; Matrix Gla protein; Mortality; Osteocalcin; Vascular calcifications; Vertebral fractures; Warfarin

Indexed keywords

25 HYDROXYVITAMIN D; MATRIX GLA PROTEIN; OSTEOCALCIN; PARATHYROID HORMONE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG; WARFARIN; ANTICOAGULANT AGENT;

AGE; AGED; ANGINA PECTORIS; ARTERY CALCIFICATION; ARTICLE; ATRIAL FIBRILLATION; BLOOD ANALYSIS; BLOOD VESSEL CALCIFICATION; BONE MINERALIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; RADIOGRAPHY; SPINE FRACTURE; SURVIVAL; ADVERSE EFFECTS; CASE CONTROL STUDY; CLINICAL TRIAL; HEMODIALYSIS; ITALY; KAPLAN MEIER METHOD; KIDNEY DISEASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; SPINAL FRACTURES; STATISTICAL MODEL; TIME FACTOR; VASCULAR CALCIFICATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS; SEX FACTORS; SPINAL FRACTURES; TIME FACTORS; VASCULAR CALCIFICATION; WARFARIN;

EID: 84989790742     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/15701611113119990146     Document Type: Article

References (36)

1. Wizemann V, Tong L, Satayathum S, et al.Atrial fibrillation in haemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 2010; 77: 1098-106
2. Holden RM, Harman GJ, Wang M. Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 105-10
3. Krueger T, Westenfeld R, Ketteler M, Schurgers LJ, Floege J. Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int 2009; 76: 18-22
4. Ducy P, Desbois C, Boyce B, et al.Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382: 448-452
5. Razzaque MS. Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism? Nephrol Dial Transplant 2011; 26: 42-5
6. Zebboudj AF, Imura M, Boström K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 2002; 277: 4388-94
7. Luo G, Ducy P, McKee MD, et al.Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81
8. Shearer MJ. Role of vitamin K and GLA proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 2000; 3: 433-8
9. Kruegert T, Floege J. Coumarin use in dialysis patients with atrial fibrillation--more harm than benefit? Nephrol Dial Transplant 2009; 24: 3284-5
10. Souberbielle JCP, Roth H, Fouque DP. Parathyroid hormone measurement in CKD. Kidney Int 2010; 77: 93-100
11. Genant HK, Jergas M, Palermo L, et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 1996; 11: 984-96
12. Guglielmi G, Diacinti D, van Kuijk C, et al. Vertebral morphometry: current methods and recent advances. Eur Radiol 2008; 18: 1484-96
13. Witteman JC, Grobbee DE, Valkenburg HA, et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994; 343: 504-507
14. Cranenburg ECM, Vermeer C, Koos R, et al. The circulating inactive form of matrix Gla Protein (UCMGB) as a biomarker for cardiovascular calcification. J Vasc Res 2008; 45: 427-436
15. Kraemer HC, Stice E, Kazdin A, et al. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001; 158: 848-856
16. Van Stralen KJ, Dekker FW, Zoccali C, Jager KJ. Confounding. Nephron Clin Pract. 2010; 116: c143-7
17. Ikonen E, Merikallio E, Osterlund K, Seppälä M. Mitral-valve prosthesis, warfarin anticoagulation, and pregnancy. Lancet 1970; 12: 1252
18. Connor JM, Connor RA, Sweet EM, et al. Lethal neonatal chondrodysplasias in the West of Scotland 1970-1983 with a description of a thanatophoric, dysplasialike, autosomal recessive disorder, Glasgow variant. Am J Med Genet 1985; 22: 243-53
19. Fusaro M, Crepaldi G, Maggi S, et al. Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship. J Endocrinol Invest 2011; 34: 317-23
20. Gage BF, Birman E, Radford MJ. Risk of osteoporotic fracture in elderly patients taking warfarin: results from National Registry of Atrial Fibrillation 2. Arch Intern Med 2006; 23: 241-6
21. Oury F, Ferron M, Huizhen W, et al. Osteocalcin regulates murine and human fertility through pancreas-bone-testis axis. J Clin Invest 2013; 126(6): 2421-33
22. Karsenty G. The mutual dependence between bone and gonads. J Endocrinol 2012; 213; 107-14
23. Mamdani M, Upshur RE, Anderson G, Bartle BR, Laupacis A. Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy 2003; 23: 1-4
24. Riess H, Loew A, Himmelreich G. Secondary osteoporosis induced by anticoagulants. Orthopade 2001; 30: 451-5
25. Booth SL, Mayer J. Warfarin use and fracture risk. Nutr Rev 2000; 58: 20-2
26. Schurgers LJ, Aebert H, Vermeer C, Bültmann B, Janzen J. Oral anticoagulant treatment: friend or foe in cardiovascular disease. Blood 2004; 104: 3231-2
27. Holden RM, Sanfilippo AS, Hopman WM, Zimmerman D, Garland JS, Morton AR. Warfarin and aortic valve calcification in haemodialysis patients. J Nephrol 2007; 20: 417-22
28. McCabe KM, Booth SL, FU X, et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 2013; 83(5): 835-44
29. Nakagami H, Osako MK, Morishita R. New concept of vascular calcification and metabolism. Curr Vasc Pharmacol 2011; 9 (1): 124-7
30. Chan KE, Lazarus JM, Thadhani R, Hakim RM. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. JASN 2009; 20: 2223-33
31. Dossett LA, Riesel JN, Griffin MR, Cotton BA. Prevalence and implications of pre-injury warfarin use: an analysis of the National Trauma Databank. Arch Surg 2011; 146: 565-70
32. Fusaro M, Crepaldi G, Maggi S, et al. Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies. Curr Vasc Pharmacol 2011; 9: 763-9
33. Fusaro M, Noale M, Tripepi G, et al. Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: A cross-sectional study using propensity score analysis. Drug Saf 2013; 36(8): 635-42
34. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429
35. Rodríguez-García M, Gómez-Alonso C, Naves-Díaz M, Díaz- López JB, Díaz-Corte C, Cannata-Andía JB, Asturias Study Group. Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 239-46
36. Mazzaferro S, Pasquali M, Cozzolino M. Treatment of cardiovascular calcification in uremia. Curr Vasc Pharmacol 211; 9(6): 741-9.